AMBER WILCOX: Open Payments
NPI 1255002747 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 35 payments from 14 companies in 2025. Trend: 2023 $712 · 2024 $1,252 · 2025 $696
Food & beverage: $630Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $211 |
| UCB, Inc. | 7 | $141 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $63 |
| Incyte Corporation | 2 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: TREMFYA, Bimzelx, JOURNAVX, OPZELURA, Zoryve, ILUMYA, Sotyktu, DUPIXENT.
Industry payments across TX — which companies pay providers there.
